Keyphrases
C-reactive Protein
100%
Respiratory Symptoms
100%
Antibiotics
100%
Randomized Controlled Clinical Trial
100%
Kyrgyzstan
100%
Health Centers
50%
Antibiotic Use
50%
Point-of-care Test
50%
Acute Respiratory Symptoms
33%
Primary Level
33%
Hospital Admission
16%
International Conference
16%
Cause of Death
16%
Training Session
16%
Trial Registration
16%
Clinical Evaluation
16%
Intention-to-treat
16%
Rate of Increase
16%
Healthcare Workers
16%
Inflammatory Biomarkers
16%
Linear Regression Model
16%
Medical Journals
16%
Antibiotic Resistance
16%
Logistic Regression Model
16%
Respiratory Infection
16%
Ethics Committees
16%
Childcare
16%
Central Asia
16%
Second Primary
16%
Vital Status
16%
Result Interpretation
16%
Noninferiority Margin
16%
Lower Respiratory Tract Infection
16%
Clinical Uncertainty
16%
National Center
16%
Admission Status
16%
Lowland
16%
Protein Testing
16%
Reconsultation
16%
Acute Respiratory Infection
16%
Maternity Care
16%
Antibiotic Overuse
16%
Children under 5
16%
Non-inferiority Analysis
16%
Short Training
16%
Highlands
16%
Policy Brief
16%
Protein Use
16%
Business Hours
16%
Bishkek
16%
Naryn
16%
Pharmacology, Toxicology and Pharmaceutical Science
C Reactive Protein
100%
Controlled Clinical Trial
100%
Symptom
100%
Antibiotics
100%
Antibiotic Agent
100%
Respiratory Tract Infection
40%
Inflammation
20%
Biological Marker
20%
Clinical Trial
20%
Antibiotic Resistance
20%
Lower Respiratory Tract Infection
20%
Nursing and Health Professions
Symptom
100%
C Reactive Protein
100%
Antibiotic Agent
100%
Respiratory Tract Infection
40%
Biological Marker
20%
Inflammation
20%
Intention to Treat Analysis
20%
Logistic Regression Analysis
20%
Health Care Personnel
20%
Clinical Evaluation
20%
Linear Regression Analysis
20%
Professional Standard
20%
Antibiotic Resistance
20%
Lower Respiratory Tract Infection
20%
Medicine and Dentistry
C Reactive Protein
100%
Symptom
100%
Controlled Clinical Trial
100%
Antibiotics
100%
Consultation
20%
Respiratory Tract Infection
20%
Obstetrics
10%
Logistic Regression Analysis
10%
Biological Marker
10%
Clinical Trial
10%
Intention-to-Treat Analysis
10%
Linear Regression Analysis
10%
Antibiotic Resistance
10%
Lower Respiratory Tract Infection
10%
Clinical Uncertainty
10%